Pulmonary Drug Delivery Systems Market

1
Global Pulmonary Drug Delivery Systems Market
2017 2025

• Published by Accurize Market Research Pvt. Ltd.

2
Global Pulmonary Drug Delivery Market is
Estimated to Reach 52.9 Billion by 2025

• Global pulmonary drug delivery market report
  published by Accurize Market Research forecast
  that the global market is expected to reach 52.9
  billion by 2025 growing at a CAGR of 6.6 from
  2017 to 2025. By geography, the Asia Pacific and
  North America are expected to grow at a CAGR of
  XX and XX, respectively, during the forecast
  period.
• Request Sample 
• https//www.accurizemarketresearch.com/report/pulm
  onary-drug-delivery-systems-market/sample-request

3
Global Pulmonary Drug Delivery Market is
Estimated to Reach 52.9 Billion by 2025

• Technological developments in the field of drug
  delivery and growing demand for new products,
  changing lifestyle, ease of use and improved
  facilities across the globe to drive the growth
  of the market
• Technological developments in the field of drug
  delivery and growing demand for new products,
  changing lifestyle, ease of use and improved
  facilities fuels the demand for the global
  pulmonary drug delivery market. Moreover, the
  upsurge in the number of public and private
  organizations also boosts the growth of the
  market.

4
Market Segmentation

• The global pulmonary drug delivery market has
  been bifurcated on the basis of product,
  application, and geography. On the basis of the
  product, it is divided into metered-dose inhalers
  (breath-actuated pressurized inhaler and
  manually-actuated pressurized inhaler),
  nebulizers (jet nebulizers, ultrasonic
  nebulizers, and vibrating mesh nebulizers), and
  dry powder inhalers (single dose inhalers and
  multi-dose inhalers).
• On the basis of the distributor segment, it is
  bifurcated into Retail Pharmacies, Hospital
  Pharmacies, and E-commerce. On the basis of
  application, the market is segmented into asthma,
  cystic fibrosis, and chronic obstructive
  pulmonary disease (COPD), and others.
• Request Customization 
• https//www.accurizemarketresearch.com/report/pulm
  onary-drug-delivery-systems-market/ask-for-customi
  zation

5
Market Segmentation

• By geography, the market is segmented into North
  America, Europe, Asia-Pacific and Rest of the
  World (RoW). The U.S., Canada, and Mexico are
  covered under North America wherein Europe covers
  the UK, Germany, France, Italy, and others.
  Asia-Pacific covers China, India, Japan, South
  Korea, and others. The rest of the World covers
  South America, the Middle East, and Africa.
•  North America dominated the pulmonary drug
  delivery devices market during the forecast
  period, says accurize
• In 2017, North America dominated the pulmonary
  drug delivery devices market and Asia accounted
  for the second-largest regional market. Moreover,
  the Asia-Pacific is expected to register the
  highest CAGR during the forecast period due to
  the rapid growth of the geriatric population,
  growing acceptance of an unhealthy lifestyle,
  growing urbanization, exposure to smoke
  chemicals and the successive increase in the
  prevalence of COPD in the area

6
Top players in the market

•  
• The key market players include
• GlaxoSmithKline plc
• Novartis AG
• Koninklijke Philips N.V.
• 3M Company
• Actelion Pharmaceuticals Ltd
• AstraZeneca plc
• BoehringerIngelheimGmbh
• Clement Clarke International
• Briggs Healthcare
• Aerogenamong others
•  

7
Contact Us

• Accurize Market Research Pvt. Ltd.
• PUNE OFFICE 306, ZEN BUSINESS CENTER,
• WAKAD, NEAR BHUMKAR CHOWK,
• MUMBAI BANGALORE HIGHWAY,
• PUNE-411057
• Email help_at_accurizemarketresearch.com
• Contact No 1-339-368-6383